"Ovarian Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS.
| Descriptor ID |
D010051
|
| MeSH Number(s) |
C04.588.322.455 C13.351.500.056.630.705 C13.351.937.418.685 C19.344.410 C19.391.630.705
|
| Concept/Terms |
Ovarian Neoplasms- Ovarian Neoplasms
- Neoplasm, Ovarian
- Ovarian Neoplasm
- Ovary Neoplasms
- Neoplasm, Ovary
- Neoplasms, Ovary
- Ovary Neoplasm
- Neoplasms, Ovarian
Ovary Cancer- Ovary Cancer
- Cancer, Ovary
- Cancers, Ovary
- Ovary Cancers
- Ovarian Cancer
- Cancer, Ovarian
- Cancers, Ovarian
- Ovarian Cancers
- Cancer of Ovary
- Cancer of the Ovary
|
Below are MeSH descriptors whose meaning is more general than "Ovarian Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Ovarian Neoplasms".
This graph shows the total number of publications written about "Ovarian Neoplasms" by people in this website by year, and whether "Ovarian Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 5 | 0 | 5 |
| 1997 | 7 | 0 | 7 |
| 1998 | 2 | 1 | 3 |
| 1999 | 2 | 1 | 3 |
| 2000 | 6 | 4 | 10 |
| 2001 | 12 | 0 | 12 |
| 2002 | 2 | 2 | 4 |
| 2003 | 4 | 1 | 5 |
| 2004 | 4 | 2 | 6 |
| 2005 | 7 | 1 | 8 |
| 2006 | 7 | 1 | 8 |
| 2007 | 8 | 2 | 10 |
| 2008 | 12 | 5 | 17 |
| 2009 | 18 | 2 | 20 |
| 2010 | 13 | 3 | 16 |
| 2011 | 19 | 2 | 21 |
| 2012 | 23 | 5 | 28 |
| 2013 | 14 | 2 | 16 |
| 2014 | 26 | 4 | 30 |
| 2015 | 29 | 1 | 30 |
| 2016 | 24 | 4 | 28 |
| 2017 | 28 | 1 | 29 |
| 2018 | 23 | 3 | 26 |
| 2019 | 33 | 5 | 38 |
| 2020 | 14 | 1 | 15 |
| 2021 | 30 | 2 | 32 |
| 2022 | 26 | 1 | 27 |
| 2023 | 34 | 0 | 34 |
| 2024 | 19 | 3 | 22 |
| 2025 | 20 | 0 | 20 |
| 2026 | 11 | 0 | 11 |
To return to the timeline,
click here.
Below are the most recent publications written about "Ovarian Neoplasms" by people in Profiles.
-
Palbociclib in Patients With Ovarian Cancer With CDKN2A Alterations: Results From the Targeted Agent and Profiling Utilization Registry Study. JCO Precis Oncol. 2026 Jul; 10(7):e2600456.
-
Real-world genetic testing data of ovarian cancer patients: Informing counseling and risk reduction in patients over age seventy. Gynecol Oncol. 2026 06; 209:77-87.
-
Pertuzumab and Trastuzumab in Patients With ERBB2/3-Altered Urothelial or Ovary/Fallopian Tube Cancer: Results From the Targeted Agent and Profiling Utilization Registry Study. JCO Precis Oncol. 2026 Apr; 10(4):e2501250.
-
Rethinking ovarian cancer III: the past decade and future directions. Nat Rev Cancer. 2026 Jun; 26(6):452-471.
-
"Showing some care": interest-holders' perspectives on addressing health-related social conditions in ovarian cancer. Oncologist. 2026 Mar 09; 31(4).
-
Epitranscriptomic signatures of malignancy: how RNA modifications shape breast and ovarian tumor progression. Biochem Pharmacol. 2026 Jun; 248:117872.
-
Ovarian cancer cell glucocorticoid receptor activation increases myeloid-derived suppressor cell tumor infiltration. Endocrinology. 2026 Mar 06; 167(4).
-
DART/SWOG/NCI phase II anti-CTLA-4/PD-1 trial: clear cell carcinomas of ovary, endometrium, cervix. J Immunother Cancer. 2026 Feb 11; 14(2).
-
Emerging trends and treatment strategies in ovarian cancer: A comprehensive review. Crit Rev Oncol Hematol. 2026 Apr; 220:105177.
-
NCCN Guidelines® Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, Pancreatic, and Prostate, Version 2.2026. J Natl Compr Canc Netw. 2026 02; 24(2):2-10.